Journal of Clinical Pathology 2008;61:897-902
MY APPROACH
Pathology of sentinel lymph nodes for melanoma
Postgraduate Medical School, University of Surrey and Department of Histopathology, Royal Surrey County Hospital, Guildford, Surrey, UK
Correspondence to:
Professor M G Cook, Royal Surrey County Hospital, Egerton Road, Guildford, Surrey GU2 7XX, UK; m.cook{at}nhs.net
As a concept sentinel lymph node biopsy seems attractive in that it attempts to identify the first lymph node, rather than the nearest node, draining a particular anatomic area where a tumour has arisen. Pathological assessment can then indicate whether metastases are present and the procedure is either a strong prognostic indicator or possibly therapeutic in itself. These comments apply to any tumour type, but with melanoma the pathological procedure is more problematic and any benefits above prognosis and staging are not universally accepted. The procedure does give accurate staging without the extra morbidity of regional node dissection and many patients gain psychological support from the information gained.
This article has been cited by other articles:
-
Bataille, V., Glass, D.
(2009). Melanoma: risk factors and controversies. Clin Risk
15: 3-7
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
